c-kit expression in small cell carcinoma of the urinary bladder: Prognostic and therapeutic implications

Chong Xian Pan, Ximing J. Yang, Antonio Lopez-Beltran, Gregory T. MacLennan, John Eble, Michael Koch, Timothy D. Jones, Haiqun Lin, Kelly Nigro, Veronica Papavero, Maria Tretiakova, Liang Cheng

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

The prognosis for small cell carcinoma of the urinary bladder is poor, and strategies for improved therapy are needed. Targeted therapy against the c-kit proto-oncogene has been successful in the management of gastrointestinal stromal tumor. We investigated the expression of c-kit in 52 cases of small cell carcinoma of the urinary bladder. Specimens with more than 10% of cells demonstrating strong membrane staining were considered to have positive immunostaining for c-kit. c-kit expression was detected in 21 of 52 specimens from these patients. Among the 21 specimens, seven had less than 10% staining, and were considered to be negative. Nine had 11-50% staining, and five had more than 50% staining. Overall, 14 of 52 (27%) small cell carcinomas of the urinary bladder were positive for c-kit expression. During a median follow-up of 11 months, 60% of the patients died of bladder cancer. No association was found between c-kit expression and survival or other clinicopathologic parameters. Five-year cancer-specific survivals for c-kit-positive and c-kit-negative tumors were 9 and 15%, respectively (P = 0.35). A significant proportion (27%) of small cell carcinomas of the urinary bladder expressed c-kit, suggesting that it may prove useful as a therapeutic target in small cell carcinoma of the urinary bladder.

Original languageEnglish
Pages (from-to)320-323
Number of pages4
JournalModern Pathology
Volume18
Issue number3
DOIs
StatePublished - Mar 2005

Fingerprint

Small Cell Carcinoma
Urinary Bladder
Staining and Labeling
Therapeutics
Gastrointestinal Stromal Tumors
Survival
Proto-Oncogenes
Urinary Bladder Neoplasms
Neoplasms
Membranes

Keywords

  • c-kit, prognosis
  • Neoplasm
  • Small cell carcinoma
  • Urinary bladder

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

c-kit expression in small cell carcinoma of the urinary bladder : Prognostic and therapeutic implications. / Pan, Chong Xian; Yang, Ximing J.; Lopez-Beltran, Antonio; MacLennan, Gregory T.; Eble, John; Koch, Michael; Jones, Timothy D.; Lin, Haiqun; Nigro, Kelly; Papavero, Veronica; Tretiakova, Maria; Cheng, Liang.

In: Modern Pathology, Vol. 18, No. 3, 03.2005, p. 320-323.

Research output: Contribution to journalArticle

Pan, CX, Yang, XJ, Lopez-Beltran, A, MacLennan, GT, Eble, J, Koch, M, Jones, TD, Lin, H, Nigro, K, Papavero, V, Tretiakova, M & Cheng, L 2005, 'c-kit expression in small cell carcinoma of the urinary bladder: Prognostic and therapeutic implications', Modern Pathology, vol. 18, no. 3, pp. 320-323. https://doi.org/10.1038/modpathol.3800318
Pan, Chong Xian ; Yang, Ximing J. ; Lopez-Beltran, Antonio ; MacLennan, Gregory T. ; Eble, John ; Koch, Michael ; Jones, Timothy D. ; Lin, Haiqun ; Nigro, Kelly ; Papavero, Veronica ; Tretiakova, Maria ; Cheng, Liang. / c-kit expression in small cell carcinoma of the urinary bladder : Prognostic and therapeutic implications. In: Modern Pathology. 2005 ; Vol. 18, No. 3. pp. 320-323.
@article{b09f20b365794dd2a96b44531a3416f2,
title = "c-kit expression in small cell carcinoma of the urinary bladder: Prognostic and therapeutic implications",
abstract = "The prognosis for small cell carcinoma of the urinary bladder is poor, and strategies for improved therapy are needed. Targeted therapy against the c-kit proto-oncogene has been successful in the management of gastrointestinal stromal tumor. We investigated the expression of c-kit in 52 cases of small cell carcinoma of the urinary bladder. Specimens with more than 10{\%} of cells demonstrating strong membrane staining were considered to have positive immunostaining for c-kit. c-kit expression was detected in 21 of 52 specimens from these patients. Among the 21 specimens, seven had less than 10{\%} staining, and were considered to be negative. Nine had 11-50{\%} staining, and five had more than 50{\%} staining. Overall, 14 of 52 (27{\%}) small cell carcinomas of the urinary bladder were positive for c-kit expression. During a median follow-up of 11 months, 60{\%} of the patients died of bladder cancer. No association was found between c-kit expression and survival or other clinicopathologic parameters. Five-year cancer-specific survivals for c-kit-positive and c-kit-negative tumors were 9 and 15{\%}, respectively (P = 0.35). A significant proportion (27{\%}) of small cell carcinomas of the urinary bladder expressed c-kit, suggesting that it may prove useful as a therapeutic target in small cell carcinoma of the urinary bladder.",
keywords = "c-kit, prognosis, Neoplasm, Small cell carcinoma, Urinary bladder",
author = "Pan, {Chong Xian} and Yang, {Ximing J.} and Antonio Lopez-Beltran and MacLennan, {Gregory T.} and John Eble and Michael Koch and Jones, {Timothy D.} and Haiqun Lin and Kelly Nigro and Veronica Papavero and Maria Tretiakova and Liang Cheng",
year = "2005",
month = "3",
doi = "10.1038/modpathol.3800318",
language = "English",
volume = "18",
pages = "320--323",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - c-kit expression in small cell carcinoma of the urinary bladder

T2 - Prognostic and therapeutic implications

AU - Pan, Chong Xian

AU - Yang, Ximing J.

AU - Lopez-Beltran, Antonio

AU - MacLennan, Gregory T.

AU - Eble, John

AU - Koch, Michael

AU - Jones, Timothy D.

AU - Lin, Haiqun

AU - Nigro, Kelly

AU - Papavero, Veronica

AU - Tretiakova, Maria

AU - Cheng, Liang

PY - 2005/3

Y1 - 2005/3

N2 - The prognosis for small cell carcinoma of the urinary bladder is poor, and strategies for improved therapy are needed. Targeted therapy against the c-kit proto-oncogene has been successful in the management of gastrointestinal stromal tumor. We investigated the expression of c-kit in 52 cases of small cell carcinoma of the urinary bladder. Specimens with more than 10% of cells demonstrating strong membrane staining were considered to have positive immunostaining for c-kit. c-kit expression was detected in 21 of 52 specimens from these patients. Among the 21 specimens, seven had less than 10% staining, and were considered to be negative. Nine had 11-50% staining, and five had more than 50% staining. Overall, 14 of 52 (27%) small cell carcinomas of the urinary bladder were positive for c-kit expression. During a median follow-up of 11 months, 60% of the patients died of bladder cancer. No association was found between c-kit expression and survival or other clinicopathologic parameters. Five-year cancer-specific survivals for c-kit-positive and c-kit-negative tumors were 9 and 15%, respectively (P = 0.35). A significant proportion (27%) of small cell carcinomas of the urinary bladder expressed c-kit, suggesting that it may prove useful as a therapeutic target in small cell carcinoma of the urinary bladder.

AB - The prognosis for small cell carcinoma of the urinary bladder is poor, and strategies for improved therapy are needed. Targeted therapy against the c-kit proto-oncogene has been successful in the management of gastrointestinal stromal tumor. We investigated the expression of c-kit in 52 cases of small cell carcinoma of the urinary bladder. Specimens with more than 10% of cells demonstrating strong membrane staining were considered to have positive immunostaining for c-kit. c-kit expression was detected in 21 of 52 specimens from these patients. Among the 21 specimens, seven had less than 10% staining, and were considered to be negative. Nine had 11-50% staining, and five had more than 50% staining. Overall, 14 of 52 (27%) small cell carcinomas of the urinary bladder were positive for c-kit expression. During a median follow-up of 11 months, 60% of the patients died of bladder cancer. No association was found between c-kit expression and survival or other clinicopathologic parameters. Five-year cancer-specific survivals for c-kit-positive and c-kit-negative tumors were 9 and 15%, respectively (P = 0.35). A significant proportion (27%) of small cell carcinomas of the urinary bladder expressed c-kit, suggesting that it may prove useful as a therapeutic target in small cell carcinoma of the urinary bladder.

KW - c-kit, prognosis

KW - Neoplasm

KW - Small cell carcinoma

KW - Urinary bladder

UR - http://www.scopus.com/inward/record.url?scp=20144381083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20144381083&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3800318

DO - 10.1038/modpathol.3800318

M3 - Article

C2 - 15502806

AN - SCOPUS:20144381083

VL - 18

SP - 320

EP - 323

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 3

ER -